SCHEMBL7830409

SCHEMBL7830409

O=c1ccn(Cc2ccccc2)c(=O)n1CCCCl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 5/20 0.44
HTT P42858 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
KDM4E B2RXH2 1/20 0.43
TP53 P04637 1/20 0.43
CYP2D6 P10635 1/20 0.43
HPGD P15428 2/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
KMT2A Q03164 1/20 0.43
NPC1 O15118 1/20 0.39
GSK3B P49841 2/20 0.39
CYP3A4 P08684 1/20 0.39
ADORA2B P29275 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
CCNB2 O95067 1/20 0.39
CDK1 P06493 1/20 0.39
CCNB1 P14635 1/20 0.39
GSK3A P49840 1/20 0.39
CCNB3 Q8WWL7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5800712 0.84 HPGD (0.49) MAPK14HTTSMN1; SMN2KDM4ETP53
SCHEMBL4474765 0.82 SMN1; SMN2 (0.42) MAPK14HTTSMN1; SMN2KDM4ETP53
SCHEMBL7821737 0.82 POLB (0.46) HTTSMN1; SMN2KDM4ECYP2D6HPGD
SCHEMBL5482630 0.76 HPGD (0.49) MAPK14CYP2D6HPGDMEN1ALDH1A1
SCHEMBL9118024 0.76 CYP3A4 (0.51) MAPK14HTTSMN1; SMN2KDM4ETP53
SCHEMBL7832968 0.75 HPGD (0.47) SMN1; SMN2HPGDMEN1KMT2AADORA2B
SCHEMBL7833125 0.74 POLB (0.43) MAPK14SMN1; SMN2TP53MEN1KMT2A
SCHEMBL7830685 0.74 KMT2A (0.58) HTTSMN1; SMN2KDM4EHPGDMEN1
SCHEMBL7821335 0.73 POLB (0.39) HTTSMN1; SMN2KDM4EHPGDMEN1
SCHEMBL5310921 0.73 PRKCA (0.38) CYP2D6MEN1KMT2AGSK3BADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0748800-B1 Pyrimidinedione, pyrimidinetrione, triazinedione derivatives as alpha-1-adrenergic receptor antagonists HOFFMANN LA ROCHE (CH) 2001-05-09 EP disclosed
US-5859014-A USEFUL IN TREATMENT OF DISEASES INVOLVING DIRECTLY OR INDIRECTLY AN OBSTRUCTION OF THE LOWER URINARY TRACT, SUCH ASBENIGN PROSTATE HYPERPLASIA SYNTEX (U.S.A.) INC. (US) 1999-01-12 US disclosed
EP-0748800-A2 Pyrimidinedione, pyrimidinetrione, triazinedione, tetrahydroquinazolinedione derivatives as alpha-1-adrenergic receptor antagonists F. HOFFMANN-LA ROCHE AG (CH) 1996-12-18 EP disclosed